Skip to main content
Fig. 1 | Pediatric Rheumatology

Fig. 1

From: Implementation study of the CARRA Uveitis Consensus Treatment Plans: feasibility for clinical practice and applicability for research

Fig. 1

Outline of uveitis consensus treatment plan algorithm. Flowchart depicting CTP algorithms. Dosing for methotrexate (MTX) is 0.5–1 mg/kg/week (maximum 30 mg). Adalimumab dosing is based on weight: 10 mg for 10 kg to < 15 kg, 20 mg for 15 kg to < 30 kg; 40 mg for > / = 30 kg. Dose escalation of adalimumab consists of doubling the biweekly dose if on 10 mg of 20 mg. Infliximab dosing starts at 6–10 mg/kg, with a recommended loading regimen of infusions at 0 and 2 weeks, followed by every 4 weeks thereafter. Dose escalation of infliximab is permitted up to maximum dose of 20 mg/kg

Back to article page